APR 01, 2020 7:33 PM PDT

New immunotherapy for ovarian cancer

Research published recently in the Journal of Experimental Medicine suggests that targeting macrophages in a new kind of immunotherapy could provide hope for patients with malignant ovarian cancer, which is known to be particularly difficult to diagnose. Because diagnosis remains difficult, only four out of six patients on average are still alive after five years, making effective treatment options all the more imperative.

Researchers from Aarhus University, Denmark have used mice models to show how it is possible to remove macrophage from omental fat in order to slow the spread of ovarian cancer. Omental fat is found in the abdominal cavity close to the intestines where it can act as an energy source for migrating cancer cells that originate in the fallopian tubes.

"This is where the omental fat becomes a kind of host for cells which would otherwise perish, and our research now shows that when tumor cells move into the omental fat, two specific types of immune cells known as macrophages alter character. They develop into the disease's small supporters," says Anders Etzerodt, lead author of the study. Anders Etzerodt is Ph.D. and assistant professor of cancer immunology at the Department of Biomedicine at Aarhus University.

"One of the macrophage types which is already present in the tissue simply begins to help the tumor spread further to the other organs in the abdominal cavity. At the same time, the second type of macrophage, which comes from the bloodstream and is recruited as a reaction to the infiltration of tumor cells into the omental fat, begins to counteract the immune system's attempt to fight the invasive cancer cells. In this way, they help the tumor to grow larger," explains Anders Etzerodt.

Hence, by removing these macrophages is both the affected tumors and the bloodstream, the researchers were able to simultaneously slow the spread of the tumors and shrink their sizes. While they have only tested their findings in mice thus far, they hope to develop a drug for human trials, both for ovarian cancer as well as skin cancer and potentially pancreatic cancer.

Speaking of the team’s findings, Anders Etzerodt comments, "We describe a type of immunotherapy which differs from the immunotherapy that is characterized by supporting the T-cells that kill a tumor, and which has become an established part of modern immunological treatment. What we're doing is also immunotherapy, but it focuses on another part of the immune system. This project is only the third scientific article to describe how macrophages with different origins affect tumor development, and precisely how the macrophages that are found to inhibit the immune system's ability to hamper the cancer can be removed. They 'put the brakes on the brake', if you will," he explains.

Sources: Journal of Experimental Medicine, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 29, 2021
Cancer
New device detects skin cancer from tensile stiffness
MAY 29, 2021
New device detects skin cancer from tensile stiffness
A research team composed of scientists from City University of Hong Kong (CityU) has designed an automated non-invasive ...
JUN 08, 2021
Immunology
Fueling the Immune System's Killers
JUN 08, 2021
Fueling the Immune System's Killers
There’s a group of “killers” protecting your body against infections and eliminating potentially cance ...
JUN 16, 2021
Cancer
New drug attacks pancreatic tumors with mutant KRAS addiction
JUN 16, 2021
New drug attacks pancreatic tumors with mutant KRAS addiction
Pancreatic cancer is notoriously difficult to detect in early stages, which is why it is associated with a low survival ...
JUN 18, 2021
Cancer
Cancer cell lines are too dissimilar from human cancer cells
JUN 18, 2021
Cancer cell lines are too dissimilar from human cancer cells
A new study finds cultured cancer cells lack genetic similarity to humans. This is concerning because cancer cell lines ...
JUL 18, 2021
Cancer
Light Alcohol Use Linked to Higher Cancer Risk
JUL 18, 2021
Light Alcohol Use Linked to Higher Cancer Risk
Moderate alcohol use is linked to a substantially higher risk of several forms of cancer, including breast, colon, and o ...
JUL 26, 2021
Genetics & Genomics
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
JUL 26, 2021
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
Many types of cells have to be replenished continuously throughout our lives, and the genome in the nucleus of those cel ...
Loading Comments...